GGD-29005-74220
1 vaccination
1 coded response
10 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 16-20
- ZIP prefix
- 336 / FL
- Registered
- 2022-01-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-01-05
Registered in v-safe
-
2022-01-05
Dose 1 — Pfizer-BioNTech
-
2022-01-05
Survey response — day 0, dose 1MedDRA: Anxiety, Nausea — Feeling: Fair · Site: Pain · NauseaFree text: nausea could be due to anxietyMedDRA releases: 2024-11 · check-in free text available
-
2022-01-06
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-01-07
- 2022-01-08
- 2022-01-09
- 2022-01-10
- 2022-01-11
- 2022-01-12
- 2022-01-20
- 2022-01-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-01-05 | Pfizer-BioNTech | No |
Free text
Release 10 — day 0, dose 1
Systemic reaction (other): nausea could be due to anxiety
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Anxiety | · | · | ✓ |
| SRO | Nausea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release